Synonyms: SCE-2787
cefozopran is an approved drug (Japan)
Compound class:
Synthetic organic
Comment: Cefozopran is a fourth generation cephalosporin, belonging to the β-lactam class of antibacterial compounds. It has broad-spectrum activity and was developed by Takeda for parenteral treatment of infections caused by a range of Gram-positive and Gram-negative bacteria [1-2].
|
|
References |
1. Iwahi T, Okonogi K, Yamazaki T, Shiki S, Kondo M, Miyake A, Imada A. (1992)
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother, 36 (7): 1358-66. [PMID:1510428] |
2. Miyake A, Yoshimura Y, Yamaoka M, Nishimura T, Hashimoto N, Imada A. (1992)
Studies on condensed-heterocyclic azolium cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)- alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl cephalosporins including SCE-2787. J Antibiot (Tokyo), 45 (5): 709-20. [PMID:1624373] |